Scholarly Index
Ann M. Arvin
VIR Biotechnology (United States); 26,527 total citations; 389 total publications; best world rank #7
VIR Biotechnology (United States)
26,527Total citations
389Total publications
89H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Herpesvirus Infections and Treatments | Lifetime | 18 | US 14 | 99.74 |
| Cytomegalovirus and herpesvirus research | Lifetime | 32 | US 22 | 99.64 |
| Poxvirus research and outbreaks | Lifetime | 7 | US 5 | 99.64 |
| Animal Virus Infections Studies | Lifetime | 104 | US 51 | 99.28 |
| Virus-based gene therapy research | Lifetime | 205 | US 146 | 99.23 |
| Toxin Mechanisms and Immunotoxins | Lifetime | 80 | US 46 | 98.76 |
| Bartonella species infections research | Lifetime | 13 | US 5 | 98.62 |
| Parvovirus B19 Infection Studies | Lifetime | 86 | US 44 | 98.70 |
| Vector-borne infectious diseases | Lifetime | 280 | US 145 | 98.02 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 986 | US 330 | 97.01 |
| Virology and Viral Diseases | Lifetime | 428 | US 209 | 96.83 |
| interferon and immune responses | Lifetime | 689 | US 299 | 96.07 |
| Herpesvirus Infections and Treatments | 2021-2025 | 550 | US 175 | 83.69 |
| Toxin Mechanisms and Immunotoxins | 2021-2025 | 649 | US 98 | 63.05 |